Beurs gesloten -
Hong Kong S.E.
10:08:20 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,67
HKD
|
-0,87%
|
|
+1,61%
|
+18,87%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
3.418
|
3.507
|
2.053
|
2.848
|
2.820
|
4.164
|
4.164
|
-
|
Bedrijfswaarde
1 |
2.540
|
2.677
|
2.053
|
2.848
|
820,3
|
3.436
|
1.292
|
825,2
|
K/w-verhouding
|
7,54
x
|
44,4
x
|
4,21
x
|
4,91
x
|
4,16
x
|
4,42
x
|
4,6
x
|
4,07
x
|
Dividendrendement
|
4,27%
|
4,41%
|
9,15%
|
-
|
7,29%
|
5,72%
|
6,67%
|
7,81%
|
Marktkapitalisatie/omzet
|
1,85
x
|
2,03
x
|
1,17
x
|
-
|
1,21
x
|
1,33
x
|
1,42
x
|
1,24
x
|
Bedrijfswaarde/omzet
|
1,38
x
|
1,55
x
|
1,17
x
|
-
|
0,35
x
|
1,33
x
|
0,44
x
|
0,25
x
|
Bedrijfswaarde/EBITDA
|
3,55
x
|
4,76
x
|
3,03
x
|
-
|
1,1
x
|
4,13
x
|
1,15
x
|
0,65
x
|
Bedrijfswaarde/FCF
|
4.529.320
x
|
13.151.706
x
|
2.508.919
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1,58
x
|
1,76
x
|
0,95
x
|
-
|
0,94
x
|
1,09
x
|
0,93
x
|
0,79
x
|
Aantal aandelen (in duizenden)
|
855.392
|
845.733
|
799.826
|
794.304
|
788.390
|
793.404
|
793.404
|
-
|
Referentieprijs
2 |
3,995
|
4,147
|
2,567
|
3,585
|
3,577
|
5,249
|
5,249
|
5,249
|
Datum van publicatie
|
20/03/19
|
23/03/20
|
23/03/21
|
23/03/22
|
23/03/23
|
28/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
1.844
|
1.728
|
1.753
|
-
|
2.340
|
2.590
|
2.940
|
3.364
|
EBITDA
1 |
715,7
|
562
|
676,9
|
-
|
744,8
|
832
|
1.125
|
1.271
|
Bedrijfsresultaat (EBIT)
1 |
644,2
|
488,8
|
605,1
|
-
|
668,4
|
753,9
|
1.042
|
1.208
|
Operationele Marge
|
34,93%
|
28,29%
|
34,52%
|
-
|
28,57%
|
29,11%
|
35,44%
|
35,91%
|
Resultaat voor belastingen (EBT)
1 |
616,7
|
133,7
|
583,7
|
-
|
746,4
|
863,7
|
1.023
|
1.203
|
Nettowinst (verlies)
1 |
465,4
|
79,82
|
498,8
|
590,2
|
682,9
|
784,5
|
928,4
|
1.044
|
Nettomarge
|
25,24%
|
4,62%
|
28,46%
|
-
|
29,19%
|
30,29%
|
31,58%
|
31,04%
|
WPA
2 |
0,5300
|
0,0934
|
0,6100
|
0,7300
|
0,8600
|
0,9800
|
1,140
|
1,290
|
Free Cash Flow
|
560,9
|
203,6
|
818,4
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
30,42%
|
11,78%
|
46,69%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
78,37%
|
36,23%
|
120,89%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
120,52%
|
255,04%
|
164,07%
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,1706
|
0,1828
|
0,2349
|
-
|
0,2606
|
0,3000
|
0,3500
|
0,4100
|
Datum van publicatie
|
20/03/19
|
23/03/20
|
23/03/21
|
23/03/22
|
23/03/23
|
28/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
877
|
830
|
-
|
-
|
2.000
|
2.194
|
2.872
|
3.339
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
561
|
204
|
818
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
23,8%
|
3,85%
|
23,7%
|
-
|
23,7%
|
22,3%
|
25%
|
23,5%
|
ROA (netto-inkomsten/totale activa)
|
12,5%
|
2,1%
|
13%
|
-
|
14,8%
|
14,4%
|
17%
|
16,3%
|
Totale activa
1 |
3.735
|
3.803
|
3.829
|
-
|
4.628
|
5.208
|
5.461
|
6.426
|
Nettoactief per aandeel
2 |
2,520
|
2,350
|
2,700
|
-
|
3,800
|
4,830
|
5,670
|
6,650
|
Cashflow per aandeel
2 |
0,8600
|
-
|
-
|
-
|
-
|
0,9700
|
1,120
|
1,290
|
Capex
1 |
193
|
180
|
48,7
|
-
|
-
|
98
|
140
|
144
|
Capex/omzet
|
10,49%
|
10,4%
|
2,78%
|
-
|
-
|
3,71%
|
4,76%
|
4,28%
|
Datum van publicatie
|
20/03/19
|
23/03/20
|
23/03/21
|
23/03/22
|
23/03/23
|
28/03/24
|
-
|
-
|
Laatste slotkoers
5,249
CNY Gemiddelde koersdoel
7,272
CNY Spread / Gemiddelde doel +38,54% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +18,87% | 575 mln. | | +19,62% | 43,34 mld. | | +20,44% | 21,96 mld. | | +10,86% | 14,09 mld. | | +13,07% | 13,64 mld. | | +37,46% | 11,43 mld. | | -8,59% | 6,86 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +8,46% | 5,22 mld. |
Generieke geneesmiddelen
|